 | Zacks: Brokerages Expect Savara Inc (NASDAQ:SVRA) Will Post Earnings of -$0.44 Per Share
www.americanbankingnews.com - October 21 at 1:16 PM |
 | Have Insiders Been Buying Savara Inc. (NASDAQ:SVRA) Shares? - Yahoo Finance
finance.yahoo.com - October 15 at 7:05 PM |
| Have Insiders Been Buying Savara Inc. (NASDAQ:SVRA) Shares?
finance.yahoo.com - October 15 at 2:04 PM |
| Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - October 8 at 10:17 AM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA - Yahoo Finance
finance.yahoo.com - October 7 at 11:06 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA
finance.yahoo.com - October 7 at 11:06 PM |
| Company News For Oct 3, 2019 - Yahoo Finance
finance.yahoo.com - October 3 at 8:49 PM |
 | Thin ranks among premarket gainers - Seeking Alpha
seekingalpha.com - October 3 at 8:49 PM |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Savara Inc. (SVRA) - Yahoo Finance
finance.yahoo.com - October 3 at 3:49 PM |
| Company News For Oct 3, 2019
finance.yahoo.com - October 3 at 3:48 PM |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Savara Inc. (SVRA)
finance.yahoo.com - October 3 at 3:48 PM |
| LADENBURG THALM/SH SH Reaffirms Hold Rating for Savara (NASDAQ:SVRA)
www.americanbankingnews.com - October 3 at 3:39 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. – SVRA - Yahoo Finance
finance.yahoo.com - October 3 at 9:18 AM |
 | 31 Stocks Moving In Wednesday's Mid-Day Session - Benzinga
www.benzinga.com - October 3 at 4:18 AM |
| Mid-Day Market Update: United Natural Foods Falls On Downbeat Q4 Results; Immuron Shares Surge - Benzinga
www.benzinga.com - October 2 at 9:43 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. – SVRA
finance.yahoo.com - October 2 at 9:43 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. – SVRA
www.benzinga.com - October 2 at 6:22 PM |
 | Savara shares slide 48% premarket after FDA rejects lung-disease treatment Molgradex
www.marketwatch.com - October 2 at 4:42 PM |
| Savara Announces FDA Response From Type C Meeting on Molgradex for aPAP Development Program
finance.yahoo.com - October 2 at 4:42 PM |
| Zacks: Brokerages Anticipate Savara Inc (NASDAQ:SVRA) to Announce -$0.43 Earnings Per Share
www.americanbankingnews.com - September 29 at 12:17 AM |
| Savara and AIM ImmunoTech among healthcare gainers; Clovis Oncology and Neogen among losers - Seeking Alpha
seekingalpha.com - September 24 at 4:04 PM |
| Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS - Yahoo Finance
finance.yahoo.com - September 18 at 8:15 PM |
| Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS
finance.yahoo.com - September 18 at 8:15 PM |
| Edited Transcript of MSTX earnings conference call or presentation 8-Aug-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - August 10 at 8:09 AM |
| Savara Inc. (SVRA) CEO Rob Neville on Q2 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 9 at 8:26 AM |
 | Savara Reports Second Quarter 2019 Financial Results and Provides Business Update - Business Wire
www.businesswire.com - August 9 at 8:26 AM |
| Savara Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 9 at 8:26 AM |
 | Savara to Report Second Quarter 2019 Financial Results and Provide Business Update - StreetInsider.com
www.streetinsider.com - August 3 at 7:43 AM |
| Savara to Present at the 39th Annual Canaccord Genuity Global Growth Conference - Yahoo Finance
finance.yahoo.com - July 31 at 9:06 AM |
| Savara to Present at the 39th Annual Canaccord Genuity Global Growth Conference
finance.yahoo.com - July 31 at 9:06 AM |
| Some Savara (NASDAQ:SVRA) Shareholders Have Taken A Painful 79% Share Price Drop
finance.yahoo.com - July 15 at 7:07 PM |
| Hedge Funds Have Never Been More Bullish On Savara, Inc. (SVRA) - Yahoo Finance
finance.yahoo.com - June 26 at 8:21 AM |
| Hedge Funds Have Never Been More Bullish On Savara, Inc. (SVRA)
finance.yahoo.com - June 26 at 8:20 AM |
| Savara to Present at the JMP Securities Life Sciences Conference - Business Wire
www.businesswire.com - June 15 at 8:02 AM |
 | Why HEXO, Savara, and Cooper-Standard Holdings Slumped Today - The Motley Fool
www.fool.com - June 13 at 7:43 PM |
| Savara to Present at the JMP Securities Life Sciences Conference - Yahoo Finance
finance.yahoo.com - June 13 at 7:43 PM |
| Here's Why Savara Pharmaceuticals Collapsed Today - The Motley Fool
www.fool.com - June 13 at 7:43 PM |
| Savara Plunges After Lung Disease Drug Fails Phase 3 Trial
finance.yahoo.com - June 13 at 7:43 PM |
| Savara to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 7:43 PM |
 | U.S. STOCKS ON THE MOVE-Beyond Meat, Twitter, Uber, Lyft, Energy companies - Nasdaq
www.nasdaq.com - June 13 at 12:51 PM |
| U.S. STOCKS ON THE MOVE-RH, Lululeon, Tyson Foods, Beyond Meat - Nasdaq
www.nasdaq.com - June 13 at 12:51 PM |
| The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes - Benzinga
www.benzinga.com - June 13 at 12:51 PM |
| Here's Why Savara Pharmaceuticals Collapsed Today - Yahoo Finance
finance.yahoo.com - June 13 at 12:51 PM |
| Savara Plunges on Failure of Late-Stage Study on Molgradex - Yahoo Finance
finance.yahoo.com - June 13 at 12:51 PM |
| Here's Why Savara Pharmaceuticals Collapsed Today
finance.yahoo.com - June 13 at 12:51 PM |
 | Savara Shares Slammed on Failed Phase 3 Drug Study - TheStreet.com
www.thestreet.com - June 12 at 5:53 PM |
| Savara stock plummets 75% after drug study fails to hit target - MarketWatch
www.marketwatch.com - June 12 at 5:53 PM |
| Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)
finance.yahoo.com - June 12 at 5:53 PM |
| Savara stock plummets 75% after drug study fails to hit target
finance.yahoo.com - June 12 at 5:53 PM |
| Savara Shares Slammed on Failed Phase 3 Drug Study
finance.yahoo.com - June 12 at 5:53 PM |
